跳至主要内容
临床试验/NCT01712295
NCT01712295Unknown4 期

New Formulation of Salicylate to Improve Treatment of Common Skin Warts

Grossman, Michael, D.P.M.1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2011年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
100
试验地点
1
主要终点
To determine if salicylate with ethyl pyruvate (SA-EP) eliminates plantar warts more quickly than salicylate (SA) alone.

研究概览

简要总结

Plantar warts on the sole of the foot are among the most common warts seen in podiatry clinics. Some patients are readily cured by simple standard of care treatments that include wart debridement (trimming or excision) and application of 17% salicylate (commercially known as Compound W)or by other treatments that may be painful and affect mobility. No treatment is consistently effective and most patients fail treatment multiple times.

Ethyl pyruvate (EP)is a common food additive noted to be 'generally regarded as safe' that may improve the activity of salicylate in wart treatment by improving the ability to penetrate and/or persist in the skin. The use of 17% salicylate with the addition of EP may improve cures of common foot plantar warts in subjects who also be receiving other standard-of-care treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
12 Years 至 75 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • evidence of skin plantar wart(s)

排除标准

  • iodine allergy

研究组 & 干预措施

17% Salicylate with Ethyl Pyruvate

Experimental

Subjects with plantar wart(s) will apply the product to warts twice a day for up to 16 weeks.

干预措施: 17% Salicylate with ethyl pyruvate (Drug)

17% salicylate

Active Comparator

subjects will apply 17% salicylate (standard of care treatment) to plantar skin wart(s) twice a day for up to 16 weeks

干预措施: Salicylates (Drug)

结局指标

主要结局

To determine if salicylate with ethyl pyruvate (SA-EP) eliminates plantar warts more quickly than salicylate (SA) alone.

时间窗: 16 weeks

Subjects' wart(s) are treated with SA or SA-EP every two weeks for up to 16 weeks.

次要结局

  • To determine if salicylate with ethyl pyruvate (SA-EP) in treatment of plantar warts causes adverse events other than those known to occur with SA (salicylate)alone.(16 weeks)

研究者

发起方
Grossman, Michael, D.P.M.
申办方类型
Indiv
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验